Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06914102 · ClinicalTrials.gov registry record
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
A clinical trial of Diabetes Mellitus, Type 2 and HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 58,387
- Enrollment target
- 1
- Study location
NCT06914102 is a study of Diabetes Mellitus, Type 2 and HFpEF - Heart Failure With Preserved Ejection Fraction that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 58,387 participants, above the 4,318-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (1252% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06914102, a study of Diabetes Mellitus, Type 2 and HFpEF - Heart Failure With Preserved Ejection Fraction, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 58,387 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real-world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Semaglutide
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58,387 participants |
| Start Date | 2025-01-14 |
| Est. Completion | 2025-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06914102
The ClinicalTrials.gov registry entry for NCT06914102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58,387 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,318-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (1252% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06914102 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06914102 about?
NCT06914102 is a clinical study titled "Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real-world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such s...
What is the current status of trial NCT06914102?
This trial is currently completed. The enrollment target is 58,387 participants. The study started on 2025-01-14. Estimated completion is 2025-06-01.
What conditions does trial NCT06914102 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, HFpEF - Heart Failure With Preserved Ejection Fraction.
What interventions are being tested in trial NCT06914102?
The interventions under investigation include: Placebo (DRUG), Semaglutide (DRUG).
Who is sponsoring clinical trial NCT06914102?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06914102 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Explore more on PlainTrial
Diabetes Mellitus, Type 2
All registered trials for this condition
HFpEF - Heart Failure With Preserved Ejection Fraction
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.